| 1 |
34281834 | Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells. | 2021 Aug |
4 |
| 2 |
30066906 | Efficacy of gefitinib‑celecoxib combination therapy in docetaxel‑resistant prostate cancer. | 2018 Oct |
2 |
| 3 |
28109113 | [Effect of sodium phenylbutyrate on the sensitivity of PC3/DTX-resistant prostate cancer cells to docetaxel]. | 2017 Novemer 20 |
3 |
| 4 |
28133913 | The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer. | 2017 Mar |
1 |
| 5 |
28872603 | Ginger Phytochemicals Inhibit Cell Growth and Modulate Drug Resistance Factors in Docetaxel Resistant Prostate Cancer Cell. | 2017 Sep 5 |
1 |
| 6 |
28928839 | Analysis of resistance-associated gene expression in docetaxel-resistant prostate cancer cells. | 2017 Sep |
1 |
| 7 |
27318090 | INPP4B reverses docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer. | 2016 Aug 26 |
2 |
| 8 |
24888374 | EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1). | 2015 Apr |
2 |
| 9 |
26182875 | A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells. | 2015 Aug 28 |
1 |
| 10 |
22990129 | Differential molecular mechanism of docetaxel-octreotide combined treatment according to the docetaxel-resistance status in PC3 prostate cancer cells. | 2013 Feb |
3 |
| 11 |
23192379 | Neuroendocrine-derived peptides promote prostate cancer cell survival through activation of IGF-1R signaling. | 2013 Jun |
1 |
| 12 |
23788635 | Residual prostate cancer cells after docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4, ERK1/2 and c-Myc. | 2013 Sep |
1 |
| 13 |
20568904 | Detecting soluble clusterin in in-vitro and in-vivo models of prostate cancer. | 2010 |
1 |
| 14 |
19153211 | Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models. | 2009 Jun |
1 |
| 15 |
19521959 | Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel. | 2009 Dec 1 |
2 |
| 16 |
19773444 | Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling. | 2009 Oct 1 |
7 |
| 17 |
18025278 | Clusterin mediates TRAIL resistance in prostate tumor cells. | 2007 Nov |
1 |
| 18 |
16357178 | Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. | 2005 Dec 15 |
1 |
| 19 |
11156248 | Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. | 2000 Dec |
1 |